| Price | 0.475p on 16-01-2026 at 19:30:07 |
|---|---|
| Change | 0.00p 0% |
| Buy | 0.50p |
| Sell | 0.45p |
| Last Trade: | Sell 218,341.00 at 0.458p |
| Day's Volume: | 307,079 |
| Last Close: | 0.475p |
| Open: | 0.475p |
| ISIN: | GB00BYW8QM32 |
| Day's Range | 0.475p - 0.475p |
| 52wk Range: | 0.35p - 0.775p |
| Market Capitalisation: | £3.95m |
| VWAP: | 0.469704p |
| Shares in Issue: | 832.28m |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
N4 Pharma Plc (N4P) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 218,341 | 0.458p | Ordinary |
15:32:46 - 16-Jan-26 |
| Buy* | 52,632 | 0.50p | Ordinary |
13:58:30 - 16-Jan-26 |
| Buy* | 26,458 | 0.50p | SI Trade |
13:58:30 - 16-Jan-26 |
| Buy* | 9,447 | 0.487p | Ordinary |
12:21:14 - 16-Jan-26 |
| Sell* | 201 | 0.45p | SI Trade |
10:59:27 - 16-Jan-26 |
| Sell* | 33,163 | 0.4575p | Ordinary |
15:43:00 - 15-Jan-26 |
| Unknown* | 6,700,000 | 0.4504p | Negotiated Trade |
14:11:00 - 15-Jan-26 |
| Unknown* | 6,700,000 | 0.45p | Negotiated Trade |
14:10:41 - 15-Jan-26 |
| Buy* | 32,784 | 0.487p | Ordinary |
11:40:22 - 15-Jan-26 |
| Sell* | 11,849 | 0.4575p | Ordinary |
11:24:14 - 15-Jan-26 |
N4 Pharma Plc (N4P) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 17th Dec 2025 7:00 am | RNS | Business and Operational Update |
| 25th Sep 2025 7:00 am | RNS | Interim Results |
| 23rd Sep 2025 7:00 am | RNS | Partnership with University of Strathclyde’s CMAC |
| 22nd Sep 2025 7:00 am | RNS | N4 Pharma’s Nuvec® Targets Lung Cancer Cells |
| 19th Sep 2025 7:00 am | RNS | Notice of Results, Analyst & Investor Presentation |
| 11th Sep 2025 7:00 am | RNS-R | Investor Event and Presentation |
| 30th Jul 2025 1:55 pm | RNS-R | Article on Nuvec®’s Potential in RNA Therapeutics |
| 14th Jul 2025 7:00 am | RNS-R | Investor Webinar |
| 8th Jul 2025 7:00 am | RNS | Directorate Change |
| 30th Jun 2025 2:15 pm | RNS | Result of AGM |
